JP Morgan Call 500 GOS 21.06.2024/ DE000JS3D115 /
| 2024-06-05 8:18:18 AM | Chg.0.000 | Bid10:00:44 PM | Ask10:00:44 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 0.002EUR | 0.00% | - Bid Size: - |
- Ask Size: - |
GOLDMAN SACHS GRP IN... | 500.00 - | 2024-06-21 | Call |
GlobeNewswire
1:53 AM
Structure Therapeutics Announces Pricing of Upsized $476 Million Public Offering
GlobeNewswire
06-05
DBV Technologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
06-05
Revolution Medicines to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
06-05
Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
06-05
Sterling Check Corp. Investigated by Block & Leviton; Investors Are Encouraged to Contact the Firm
GlobeNewswire
06-05
Madrigal Pharmaceuticals to Participate in the Goldman Sachs 45th Annual Global Healthcare Conferenc...
GlobeNewswire
06-05
Passage Bio to Present at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
06-05
SpringWorks Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conferenc...
GlobeNewswire
06-05
Apellis Pharmaceuticals to Host a Fireside Chat at the Goldman Sachs 45th Annual Global Healthcare C...
GlobeNewswire
06-05
Amicus Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
06-05
Krystal Biotech to Present at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
06-05
EyePoint Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
05-09
Attovia Therapeutics Raises $105 Million Oversubscribed Series B Financing Led by Goldman Sachs Alte...
GlobeNewswire
04-11
C.K. McWhorter Continues Goldman Sachs Communications: Potential Strong Partnership Ties
